Researchers Submit Patent Application, "System And Method For Congestive Heart Failure Biomarker Detection", for Approval (USPTO 20240341623).

Researchers have submitted a patent application for a system and method to detect congestive heart failure biomarkers, focusing on acetone monitoring. The application aims to provide noninvasive monitoring technology for heart failure patients, as current methods are invasive or unavailable for outpatient use. The patent application outlines a congestive heart failure biomarker detector and methods for monitoring acetone levels using portable skin and breath analyzers, emphasizing the importance of early monitoring and intervention in managing heart failure. The technology seeks to improve outcomes for the growing number of individuals diagnosed with heart failure in the United States. [Extracted from the article]

Copyright of Heart Disease Weekly is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)